Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Neurocrine Biosciences' Ingrezza, Crenessity to Drive H2 Ahead of 'Catalyst-Rich' 2027, RBC Says

Neurocrine Biosciences' Ingrezza, Crenessity to Drive H2 Ahead of 'Catalyst-Rich' 2027, RBC Says

MT newswireMT newswire2026/09/08 15:50
11:50 AM EDT, 09/08/2026 (MT Newswires) -- Neurocrine Biosciences' (NBIX) Ingrezza and Crenessity products are expected to drive H2 appreciation, ahead of a "catalyst-rich" 2027, RBC Capital Markets said in a Tuesday note. Sales of both Ingrezza and Crenessity remain strong for the remainder of the year, while any improvement in Vykat's performance could provide upside, the brokerage said. Ingrezza is approved for the treatment of involuntary movement disorders, Crenessity for congenital adrenal hyperplasia and Vykat for hyperphagia. A series of data readouts in 2027 serve as potential catalysts for Neurocrine Biosciences, including topline data from phase 3 studies of Osavampator in major depressive disorder, RBC said. Topline data from a phase 3 study of Direclidine in schizophrenia is also expected next year, the investment firm added. Data from a phase 1 study of CRF2 agonist NBI-'2118 in obesity and a phase 2 study of VMAT2 inhibitor NBI-'890 in tardive dyskinesia are also slated for release in 2027, according to RBC. RBC has an outperform rating and $198 price target on Neurocrine Biosciences. Price: 156.05, Change: +0.41, Percent Change: +0.26
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share

Renowned Apple and supply chain analyst Ming-Chi Kuo pointed out that Google has reduced the 2027 shipment volume of the TPU 8i series, designed by Broadcom, by about 1 million units, while planning to increase its procurement of the TPU 8t, designed by MediaTek. This move reflects that, limited by power and supply chain constraints, Google is prioritizing its computing resources towards the development of cutting-edge models.

华尔街见闻•2026/11/21 12:01
Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share